Sign in Create account

Span Divergent Limited

Healthcare · Pharmaceuticals & Biotechnology

BSE: 524727
₹24.15
▼ -1.27 (-5.00%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
47/100
Moderate
Valuation
42/100
Fairly Valued
Momentum
28/100
Bearish

QVM read Mixed signals Quality Moderate, Valuation Fairly Valued, Momentum Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹18 Cr
PE (TTM)
48.3
Industry median 36.1 (152 companies)
Price to Book
1.8
PEG (TTM)
-0.7
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-23.8
Free Cash Flow
₹-0 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
-107.89%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
-32.50%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
-17.81%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
-84.90%
as of March 31, 2025
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
-64.94%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
1.10
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.73
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
32.14
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
-31.11%
as of June 30, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
-15.41%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
23.22%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
1.80%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
1.73%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
2.04%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 6 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Debt to equity is below 0.5 (0.73)
  • No Return on equity is 15% or more (2.0%)
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

0 of 6 met
  • No Price sits in the Buy zone of its own historical PE range (Sell Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-5.0%
Low 24.1500 · High 24.1500
1W return
-18.5%
Low 24.1500 · High 29.6400
1M return
-19.2%
Low 24.1500 · High 31.3700
52W return
-23.8%
Low 24.1500 · High 34.0500
Lifetime High ₹156.0500 (July 22, 2010)
Lifetime Low ₹8.8000 (Aug. 11, 2023)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish1
Bearish5
5D
26.2
10D
27.2
20D
28.1
50D
28.1
100D
25.6
200D
19.8

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
88.3%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

24.15
Pivot
First resistance24.15
Second resistance24.15
Third resistance24.15
First support24.15
Second support24.15
Third support24.15
Day RSI34.3
Day MFI38.2
Day MACD-0.96
Day MACD signal-0.56

Beta

1M-0.16
3M-0.63
1Y-0.63
3Y0.19

Price change analysis

↓ -19.2%
Over 1 Month
LowHigh
24.1531.37
↓ -23.8%
Over 3 Months
LowHigh
24.1534.05
↓ -23.8%
Over 6 Months
LowHigh
24.1534.05
↓ -23.8%
Over 1 Year
LowHigh
24.1534.05
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 48.3 (own history: 6.2–63.4)
Sell Zone

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹0 Cr
Net profit (June 30, 2026)
₹-0 Cr
Basic EPS (June 30, 2026)
₹-0.0600

Ranks #166 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter48.13%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 48.13% in Jun 2026 qtr

All shareholding details →

Deals (Bulk & Block)

All 22 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
16 Mar 2022 SPAN FINSTOCK PRIVATE LIMITED Bulk Sell 76,040 15.5000 BSE
16 Mar 2022 PRADIPKUMAR KESHAVLAL DESAI Bulk Buy 76,439 15.5000 BSE
3 Sep 2019 TEJAL VIVEK DESAI Bulk Sell 30,000 23.6500 BSE
3 Sep 2019 VIRAL P DESAI Bulk Buy 30,188 23.6500 BSE
27 Aug 2019 PRAGATI KISHOR SHAH Bulk Sell 30,258 27.5000 BSE
27 Aug 2019 VIRAL P DESAI Bulk Buy 36,000 27.3600 BSE
17 Oct 2017 LATABEN PRADIPKUMAR DESAI Bulk Buy 91,210 46.0000 BSE
17 Oct 2017 KOKILABEN B PATEL Bulk Sell 114,200 46.0000 BSE
12 Jan 2017 PRADIPKUMAR KESHAVLAL DESAI Bulk Buy 54,000 64.9900 BSE
12 Jan 2017 ARTI NILESH PATEL Bulk Sell 54,420 64.9800 BSE

All bulk and block deals →

Corporate Actions

Full history (1 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from Span Diagnostics Ltd. to Span Divergent Limited

All corporate actions →

Corporate Announcements

All 3 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
29 Sep 2026 AGM/EGM Span Divergent Ltd-$ - 524727 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
28 Sep 2026 AGM/EGM Span Divergent Ltd-$ - 524727 - Shareholder Meeting / Postal Ballot-Outcome of AGM
21 Sep 2026 Insider Trading / SAST Span Divergent Ltd-$ - 524727 - Closure of Trading Window

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Comfortable interest coverage (32.1x)

Weaknesses

  • Low Return on Equity (2.0%)
  • Thin net profit margin (-31.1%)
  • Declining revenue YoY (-64.9%)
  • Declining profit YoY (-84.9%)

Opportunities

Data unavailable.

Threats

  • PE above 35 (48.3) -- priced for continued strong execution
  • Down 23.8% over the past year

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Span Divergent Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.